India's Nureca rises after favourable injunction from court
** Healthcare and wellness products maker Nureca NURE.NS
rises 9.5% to 333.60 rupees
** Co gets favourable injunction from commercial court
against Threpsi Solutions, ARC International and Tech-Connect
Retail
** Injunction restrains passing, selling marketing products
using NURE's registered trademark "SUPERVOLT" or any deceptively
similar mark
** Around 151,005 shares traded, ~4x the 30-day avg
** NURE fell ~34% in 2024
(Reporting by Vijay Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Nureca
See all newsIndia's Nureca hits near three-month high on Q3 profit jump
Brief: Nureca Approves Buyback Worth Up To 191.4 Mln Rupees
India's Nureca falls after Q1 profit halves amid higher costs
Brief: Nureca Ltd In-Principally Approves Merger Of Nureca Technologies With Co
Brief: Nureca Says Dr Trust And Dr Physio Products To Be Available On Swiggy Instamart Soon